Locally Advanced Biliary Tract Cancer
Drug | Drug Name | Drug Description |
---|---|---|
DB11714 | Durvalumab | An antineoplastic monoclonal antibody used to treat urothelial carcinoma and locally advanced, unresectable non-small cell lung cancer. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB11714 | Durvalumab | Programmed cell death 1 ligand 1 | target |
DB11714 | Durvalumab | Programmed cell death protein 1 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB14776 | Camrelizumab | 1 / 2 | Not Yet Recruiting | 1 |
DB00515 | Cisplatin | 1 / 2 | Not Yet Recruiting | 1 |
DB00441 | Gemcitabine | 1 / 2 | Not Yet Recruiting | 1 |
DB14765 | Rivoceranib | 1 / 2 | Not Yet Recruiting | 1 |
DB00515 | Cisplatin | 2 | Terminated | 1 |
DB00441 | Gemcitabine | 2 | Terminated | 1 |